Moreover, the administration of tPA beyond its therapeutic window of 3-4.5h post-injury significantly increases the risk of blood brain barrier (BBB) disruption and hemorrhagic transformation (HT) after ischemic stroke (4–7). Here, PLAT is linked to ischemic stroke.